Interleukin-6 Antagonists [MoA] - N0000191004
Pharmacologic Class Information
| Pharmacologic Code | N0000191004 |
| Pharmacologic Name | Interleukin-6 Antagonists |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Interleukin-6 Antagonists
The table contains 2 products whose active ingredient are classified under the same pharmacologic class Interleukin-6 Antagonists [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 73090-420 | Sylvant | Non-Proprietary Name: Siltuximab | Injection, Powder, For Solution | Intravenous | Eusa Pharma (uk) Ltd | ACTIVE | |
| 73090-421 | Sylvant | Non-Proprietary Name: Siltuximab | Injection, Powder, For Solution | Intravenous | Eusa Pharma (uk) Ltd | ACTIVE |